Spanish Version of the Balance Evaluation Systems Test and Mini Balance Evaluation Systems Test (BESTest)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03403218|
Recruitment Status : Completed
First Posted : January 18, 2018
Last Update Posted : January 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Balance||Behavioral: Case group||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||single group assignment. cross-sectional survey.|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Translation and Validation of the Spanish Version of the BESTest and Mini-BESTest|
|Actual Study Start Date :||September 18, 2017|
|Actual Primary Completion Date :||November 16, 2017|
|Actual Study Completion Date :||December 30, 2017|
Experimental: case group
BESTest, mini-BESTest, Berg scale and FES (falls efficacy scale) (in Spanish version is administrated in case group.
Behavioral: Case group
assessment of quality on posture, transfers and displacement
- Concurrent validity of Best test- 1 [ Time Frame: 1 month ]concurrent validity of BESTest compare to other model balance tests
- Psychometric properties of Spanish version of BESTest. [ Time Frame: 1 year ]To perform a detailed analysis of the psychometric properties of the BESTest Spanish version.
- Psychometric properties of Spanish version of mini-BESTest. [ Time Frame: 1 year ]To perform a detailed analysis of the psychometric properties of the mini-BESTest Spanish version.
- concurrent validity of mini-BESTest [ Time Frame: 1 month ]concurrent validity of mini-BESTest compare to Berg scale and FES.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03403218
|Facultad de Ciencias de la Salud|
|Zaragoza, Spain, 50009|
|Study Chair:||Angel Mr Lanas-Arbeloa||Instituto de Investigacion Sanitaria de Aragon|